Viewing StudyNCT03536884



Ignite Creation Date: 2024-05-06 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 12:46 PM
Study NCT ID: NCT03536884
Status: COMPLETED
Last Update Posted: 2023-09-28
First Post: 2018-05-14

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-06-13
Start Date Type: ACTUAL
Primary Completion Date: 2019-09-12
Primary Completion Date Type: ACTUAL
Completion Date: 2023-08-09
Completion Date Type: ACTUAL
First Submit Date: 2018-05-14
First Submit QC Date: May 14 2018
Study First Post Date: 2018-05-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-10-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2020-09-11
Disp First Submit QC Date: September 11 2020
Disp First Post Date: 2020-09-14
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-08-07
Last Update Post Date: 2023-09-28
Last Update Post Date Type: ACTUAL